RET L730M Recombinant humaan actief eiwit Kinase
Gecertificeerd

RET L730M Recombinant humaan actief eiwit Kinase

Catalog #: HY-E70772
Maat: 1 Each

Kwaliteit

ISO Gecertificeerd

Levering

24-48 uur

Prijs -1%
Login voor prijs
BTW niet inbegrepen
Gratis verzending vanaf €100

Technische Specificaties

Description

Rearranged during transfection (RET) is a transmembrane receptor protein tyrosine kinase (PTK) activated normally by forming ternary complexes with its cognate ligands and co-receptors. RET alterations by point mutations and gene fusions were found in diverse cancers. RET L730M is a mutant of RET. RET L730M Recombinant Human Active Protein Kinase is a recombinant RET L730M protein that can be used to study RET L730M-related functions[1].

UNSPSC

12352211

Target

RET

Related Pathways

Protein Tyrosine Kinase/RTK

Field of Research

Cancer

Smiles

[RETL730MRecombinantHumanActiveProteinKinase]

References & Citations

[1]Liu X, et al. RET kinase alterations in targeted cancer therapy. Cancer Drug Resist. 2020 May 11;3 (3) :472-481.

Shipping Conditions

Room temperature

Product MSDS

http://file.medchemexpress.com/batch_PDF/HY-E70772/

Scientific Category

Enzyme

Clinical Information

No Development Reported

Beschrijving

Rearranged during transfection (RET) is a transmembrane receptor protein tyrosine kinase (PTK) activated normally by forming ternary complexes with its cognate

Specificaties

ProductnaamRET L730M Recombinant humaan actief eiwit Kinase
Categorie
Beschikbare grootte1 Each
CatalogusnummerHY-E70772